Stocks and Investing Stocks and Investing
Wed, September 4, 2024
Tue, September 3, 2024

Patrick Trucchio Reiterated (ARWR) at Strong Buy and Held Target at $60 on, Sep 3rd, 2024


Published on 2024-10-28 14:01:06 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $60 on, Sep 3rd, 2024.

Patrick has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024


These are the ratings of the 3 analyists that currently disagree with Patrick


  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $55 on, Monday, August 12th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Wednesday, July 17th, 2024
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, June 20th, 2024